All Sinovac Biotech support phone numbers are listed below, including Headquaters support phone number(s), Media support phone number(s), Investors/ Franchasing support phone number(s), etc. You can also get Sinovac Biotech support via email, social networks, help center, or directly check all the customer service contacts of Sinovac Biotech.
| [Headquaters] support phone number | +86 108 289 0088 |
| [Media] support phone number | +86 108 279 9305 |
| [Investors/ Franchasing] support phone number | +86 108 279 9659 |
| [Investors/ Franchasing] support phone number | +86 108 279 9696 |
|
[Sales/ Reservations] support phone number
(International Sales) |
+86 108 279 9382 |
|
[Sales/ Reservations] support phone number
(International Sales) |
+86 108 279 9657 |
|
[General Info] support phone number
(Sinovac Life Sciences Co., Ltd.) |
+86 105 689 7188 |
|
[General Info] support phone number
(Sinovac（Dalian）Vaccine Technology Co., Ltd.) |
+864 118 758 6000 |
Sinovac Biotech Overview
Sinovac Biotech Ltd., listed on the Nasdaq Global Select Market (NasdaqGS: SVA), is a high-tech biopharmaceutical company headquartered in Beijing. Through its wholly owned subsidiary, Sinovac Biotech (Hong Kong) Limited, Sinovac Biotech Co., Ltd. owns five branches as well as four production bases located in Haidan, Changping and Daxing districts of Beijing, and Dalian of Liaoning.
Following the mission of “Supply Vaccines to Eliminate Human Diseases", Sinovac is committed to the research, development, manufacturing and commercialization of vaccines for humans, as well as providing services for disease control and prevention. Sinovac’s product portfolio currently includes: the Covid-19 Vaccine (Vero Cell), Inactivated (CoronaVac®); Enterovirus Type 71 Vaccine (Vero Cell), Inactivated (Inlive®, a new drug under “Category 1 Preventative Biological Products); China’s first WHO pre-qualified Hepatitis A Vaccine (Human Diploid Cell), Inactivated (Healive®), etc.
Furthermore, Sinovac has been making great contributions to disease control and prevention in China and across the world.
Sinovac’s vaccines have successfully obtained market authorizations and/or product registration licenses from dozens of countries around the world.
| Industry | Biotechnology Research |
| Headquarters | Beijing, Beijing |
| Company size | 501-1,000 employees |
| Website | http://www.sinovac.com |